SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-153237
Filing Date
2021-05-06
Accepted
2021-05-06 16:01:25
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d138219d10q.htm 10-Q 503905
2 EX-31.1 d138219dex311.htm EX-31.1 10616
3 EX-31.2 d138219dex312.htm EX-31.2 10609
4 EX-32.1 d138219dex321.htm EX-32.1 5458
11 GRAPHIC g138219g0504025156354.jpg GRAPHIC 24396
12 GRAPHIC g138219g0504025156572.jpg GRAPHIC 9027
13 GRAPHIC g138219g0504025156728.jpg GRAPHIC 13493
  Complete submission text file 0001193125-21-153237.txt   4353012

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20210331.xml EX-101.INS 936134
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20210331.xsd EX-101.SCH 42850
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20210331_cal.xml EX-101.CAL 33411
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20210331_def.xml EX-101.DEF 269831
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20210331_lab.xml EX-101.LAB 362386
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20210331_pre.xml EX-101.PRE 313209
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 21897576
SIC: 2834 Pharmaceutical Preparations